MitoQ for Improving Vascular Health After Stroke
MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 30 (estimated)
- Sponsor
- Medical College of Wisconsin · Other
This trial is looking for stroke survivors who want to improve their blood vessel function. Participants will try an antioxidant called MitoQ and a method called ischemic conditioning to see if these help with their recovery.
You may be able to join if
- I am 18 to 85 years old.
- I had a stroke more than 6 months ago and have some weakness.
- I can give informed consent and follow simple commands.
- I speak English.
You may not be able to join if
- I need help to stand up from a chair.
- I have had blood clots or can't have compression on my legs.
- I have had severe COVID-19 symptoms for more than 6 months.
- I had a head injury in the past 6 months.
- I have another neurological disorder.
- I have peripheral vascular disease.
- I had a heart attack or irregular heartbeat in the past year.
- My resting blood pressure is too high.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityStroke survivors have compromised vascular function which may contribute to secondary stroke risk, cardiovascular disease, and may limit their exercise tolerance. Preliminary data shows a single bout of ischemic conditioning or oral ingestion of an over-the-counter antioxidant supplement called MitoQ may improve vascular function and muscle activity in individuals post-stroke.
Loading trial locations…